BioMarin Pharmaceutical
BMRN
$82.17
Share price
-9.90%
Change (1 day)
-14.02%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Cash on Hand
Cash on Hand as of December 2023 : $1.07 B
According to BioMarin Pharmaceutical's latest financial reports the company has $1.07 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
BioMarin Pharmaceutical - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.07 B | -16.86% |
| 2022-12-31 | $1.29 B | 27.39% |
| 2021-12-31 | $1.01 B | -4.83% |
| 2020-12-31 | $1.06 B | 41.33% |
| 2019-12-31 | $0.75 B | -30.48% |
| 2018-12-31 | $1.08 B | -22.33% |
| 2017-12-31 | $1.39 B | 76.78% |
| 2016-12-31 | $0.78 B | 33.25% |
| 2015-12-31 | $0.59 B | -37.3% |
| 2014-12-31 | $0.94 B | 20.45% |
| 2013-12-31 | $0.78 B | 75.24% |
| 2012-12-31 | $0.44 B | 129.54% |
| 2011-12-31 | $0.19 B | -28.83% |
| 2010-12-31 | $0.27 B | -8.84% |
| 2009-12-31 | $0.30 B | -46.29% |
| 2008-12-31 | $0.55 B | -4.41% |
| 2007-12-31 | $0.58 B | 102.74% |
| 2006-12-31 | $0.28 B | 504.38% |
| 2005-12-31 | $47.79 M | -2.1% |
| 2004-12-31 | $48.81 M | -76.34% |
| 2003-12-31 | $0.20 B | 178.94% |
| 2002-12-31 | $73.97 M | -43.57% |
| 2001-12-31 | $0.13 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $9.92 B | 824.57% | 🇫🇷 France |
 Ultragenyx RARE | $0.57 B | -46.25% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $81 M | -92.46% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $82.24 M | -92.34% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.28 B | -73.35% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.13 B | -87.18% | 🇺🇸 USA |